Safety and Efficacy of Insulin Aspart and Soluble Human Insulin in Elderly Type 2 Diabetes Patients: Results from UpGrade Observational Study

被引：0
|
作者：
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
499-P
引用
收藏
页码：A138 / A138
页数：1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [22] Efficacy and Safety of Insulin Degludec/Insulin Aspart versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
    Niu, Yan-Li
    Zhang, Ye
    Song, Zhi-Yong
    Zhao, Chuan-Zhi
    Luo, Yun
    Wang, Yan
    Yuan, Jing
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (02) : 313 - 322
  • [23] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results
    Nobels, Frank
    D'Hooge, Dirk
    Crenier, Laurent
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1017 - 1026
  • [24] Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Wojciechowski, Piotr
    Niemczyk-Szechowska, Patrycja
    Olewinska, Elzbieta
    Jaros, Patrycja
    Mierzejewska, Barbara
    Skarzynska-Duk, Joanna
    Malecki, Maciej T.
    Rys, Przemyslaw
    [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (03): : 141 - 151
  • [25] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    [J]. DIABETOLOGIA, 2019, 62 : S10 - S11
  • [26] COST-EFFECTIVENESS OF THERAPY CONVERSION FROM HUMAN SOLUBLE INSULIN TO INSULIN ASPART IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING
    Xu, Z. R.
    Ye, Q.
    Zhang, Y. Z.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A163 - A164
  • [27] Efficacy and safety of biphasic insulin aspart 30 in Russian patients with type 2 diabetes: Results of a multi-centre, clinical experience study
    Shestakova, Marina V.
    Dedov, Ivan I.
    [J]. DIABETES, 2007, 56 : A536 - A536
  • [28] Efficacy and safety of a combination of miglitol, metformin and insulin aspart in the treatment of type 2 diabetes
    Ke, Tingyu
    Cheng, Guoliang
    Tan, Liping
    Zhou, Xiangming
    Miao, Yuanyuan
    Du, Shigang
    Wang, Jia
    Pan, Yi
    Bi, Jingjie
    Zhao, Lin
    Zhi, Yunxia
    Zhao, Ling
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (10) : 2171 - 2177
  • [29] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    [J]. DIABETES, 2003, 52 : A567 - A567
  • [30] Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan
    Kawamura, Tomoyuki
    Kikuchi, Toru
    Horio, Hiroshi
    Rathor, Naveen
    Ekelund, Magnus
    [J]. ENDOCRINE JOURNAL, 2021, 68 (04) : 409 - 420
12345